Triomics

Generative AI for Oncology EHRs

San Francisco, United States · Founded 2021 · $52.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$52.0M
Last Round
$22.0M Series BMay 2026
Rounds
4

About

Triomics is helping cancer care providers by reducing the burden associated with manually reviewing patient charts. Utilizing our OncoLLM™—a family of oncology-focused language models—we are able to accelerate clinical trial enrollment, power quality improvement projects, and address many other key strategic priorities.

Summary

Triomics is a Healthcare company based in San Francisco, United States, founded in 2021. It has raised $52.0M in total across 4 rounds, most recently a $22.0M Series B round in May 2026. Investors include Lightspeed Venture Partners, General Catalyst and Battery Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMay 2026
$22.0M

Sign up to see all 4 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Triomics on Indexed.vc
<a href="https://indexed.vc/companies/triomics"><img src="https://indexed.vc/api/badge/company/triomics" alt="Triomics on Indexed.vc" width="260" height="76" /></a>